Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Galenica Aktie 36067446 / CH0360674466

10.09.2025 06:45:03

Launch of Galenica Diagnostics: Acquisition of Labor Team completed

Galenica AG / Key word(s): Takeover
Launch of Galenica Diagnostics: Acquisition of Labor Team completed

10.09.2025 / 06:45 CET/CEST


Press release

  • Labor Team will become part of the Galenica network once the acquisition is complete.
  • The fourth-largest private laboratory in Switzerland will continue to operate under the Labor Team brand as part of the new Galenica Diagnostics business unit.
  • The Board of Directors is made up of members of Galenica and laboratory experts.

Galenica has successfully completed the acquisition of Diagnostics Group GmbH (Labor Team Group including labor team w ag), one of Switzerland’s leading diagnostic service providers. The transaction was completed on 9 September 2025 with the approval of the Federal Competition Commission (COMCO) around two months after the acquisition was announced. By purchasing Labor Team, Galenica is entering the diagnostics business.

Management and laboratory expertise on the Board of Directors

In future, Labor Team will be managed as an independent “Galenica Diagnostics” business unit in the Products & Care segment. The company will continue to operate on the market as a legally independent entity and brand. The new Board of Directors of labor team w ag brings together the management experience of the Galenica Group and specialist laboratory expertise. The current chairman of the board of directors, Ole Wiesinger, will continue to ensure stability in this role. Thomas Szuran, Chief Products & Home Care at Galenica, Julian Fiessinger, CFO of Galenica as well as Christian Rebhan, CEO Tentamus Group, and Ralph Panoff (current) are valuable additions to the board. Rahel Kubik, who has been a member of the Board of Directors to date, will be stepping down from the Board. Labor Team and Galenica would like to thank her for her dedication over the past years. The current management team of Labor Team headed by CEO Alain M. Cahen will maintain operational responsibility.

Expanding the healthcare network

In acquiring Labor Team, Galenica is adding a leading diagnostic service provider with a strong market position to its healthcare network. In addition to the existing offerings in the area of drugs and products for the physician market, it will also be possible to offer innovative laboratory services as a single provider.

In the long term, Galenica is planning to develop an innovative range of selected diagnostic laboratory services within the scope of the regulatory possibilities in pharmacies. This will further strengthen healthcare provision in Switzerland.

Further details: Press release dated 02 July 2025

Dates for the diary

11 March 2025

Publication of Annual Results 2024 of the Galenica Group

10 April 2025

Annual General Meeting of Galenica Ltd.

7 August 2025

Publication of Galenica Group half-year results 2025

 

For further information, please contact

Media Relations
Tel. +41 58 852 85 17
E-Mail:
media@galenica.com

Investor Relations
Tel. +41 58 852 85 31
E-Mail: investors@galenica.com

Welcome to the Galenica network!

Around 8,000 employees at Galenica work tirelessly to improve the health and well-being of the people of Switzerland every day. With its pharmacies, pharmaceutical logistics providers, products, services and home care, Galenica has a broad and successful position in the market. We are shaping the future of healthcare in collaboration with our strong partners – by drawing on the diverse skills and extensive expertise of our entire network. Our ambition is to fulfil the needs of customers and patients in the Swiss healthcare market seamlessly, efficiently and personally.

Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALE, security number 36,067,446). Additional information about Galenica can be found at www.galenica.com.


About labor team 
labor team w ag is one of the leading private medical laboratories in Switzerland, with its registered office in Goldach, St. Gallen. Founded in 2001, it is now the fourth-largest laboratory in Switzerland, managed by physicians and has over 330 employees. labor team is one of the few laboratories that serves all parts of Switzerland. It offers professional services for the prevention, diagnosis, monitoring and treatment of diseases. The company covers the entire spectrum of laboratory medicine and pathology. It carries out medical tests and analyses in a state-of-the-art central laboratory, enabling top quality, great flexibility and swift order processing. Find out more at:
www.laborteam.ch



End of Media Release


Language: English
Company: Galenica AG
Untermattweg 8
3027 Bern
Switzerland
Phone: +41 058 852 81 11
E-mail: info@galenica.com
Internet: https://www.galenica.com
ISIN: CH0360674466
Listed: SIX Swiss Exchange
EQS News ID: 2194402

 
End of News EQS News Service

2194402  10.09.2025 CET/CEST

Analysen zu Galenica AG

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Krypto-Ausblick 2025: Bitcoin, Ethereum & Altcoins – Wohin geht die Reise? | BX Swiss TV

Bitcoin 2025: Steigt der Kurs noch auf 140.000 USD? Prognose & Einblicke mit Bernhard Wenger

Moderator David Kunz spricht mit Bernhard Wenger über die Zukunft von Bitcoin und Kryptowährungen. Im Gespräch geht es um Kursprognosen, die wichtigsten Einflussfaktoren auf den Kryptomarkt sowie spannende Anlageprodukte wie Indizes, Baskets und tokenisierte Assets.

Themen im Video:
🔹 Bitcoin – Kursprognose bis Jahresende: 140.000 USD möglich?
🔹 Was treiben Zinsen, Inflation & Geopolitik mit dem Kryptomarkt?
🔹 Auswirkungen der Bitcoin-ETFs in den USA
🔹 Institutionelle Investoren: Kommt jetzt der grosse Einstieg?
🔹 Welche Altcoins haben Potenzial? (Ethereum, Solana, Sui & mehr)
🔹 Baskets & Indizes: Diversifikation für Krypto-Investoren
🔹 Kombinationen wie Bitcoin & Gold im Portfolio
🔹 Tokenisierung: Die nächste grosse Welle in der Finanzwelt
🔹 Langfristige Prognosen: Was bedeutet ein einziger Bitcoin in 2030?

Krypto-Ausblick 2025: Bitcoin, Ethereum & Altcoins – Wohin geht die Reise? | BX Swiss TV

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’796.19 19.34 BVKSPU
Short 13’068.47 13.50 BDKS2U
Short 13’543.17 8.84 U2TBSU
SMI-Kurs: 12’292.72 11.09.2025 17:31:10
Long 11’752.70 18.90 SG1BPU
Long 11’496.90 13.50 BO0SVU
Long 11’026.71 8.97 BQFSFU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}